Dow Up0.08% Nasdaq Down0.30%

InVivo Therapeutics Holdings Corp. (NVIV)

-Other OTC
0.54 Up 0.04(7.94%) 3:41PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development10,533  6,376  4,103  
Selling General and Administrative8,472  6,404  4,556  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (19,005) (12,779) (8,659)
Income from Continuing Operations
Total Other Income/Expenses Net(19,621)17,515  (26,057)
Earnings Before Interest And Taxes(38,626)4,735  (34,716)
Interest Expense130  72  13  
Income Before Tax(38,756)4,664  (34,728)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(38,756)4,664  (34,728)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (38,756) 4,664   (34,728)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (38,756) 4,664   (34,728)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.